CVRx (CVRX)
(Delayed Data from NSDQ)
$8.73 USD
+0.39 (4.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $8.72 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CVRX 8.73 +0.39(4.68%)
Will CVRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CVRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVRX
CVRx (CVRX) Reports Q2 Loss, Lags Revenue Estimates
Intuitive Surgical, Inc. (ISRG) Tops Q2 Earnings and Revenue Estimates
CVRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength?
Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?
CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar?
Other News for CVRX
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Adaptive Biotechnologies (ADPT) and Rezolute (RZLT)
Lake Street Keeps Their Buy Rating on CVRx (CVRX)
Insider Buying Alert: President & CEO Kevin Hykes Acquires 30,000 Shares of CVRx Inc (CVRX)
CVRx Announces Increased Inpatient Payment for Barostim Procedure
CVRx announcs increased inpatient payment for barostim procedure